Gastroenterology

  • Home
  • Gastroenterology
Headache Relief Shampoo Voted #1 Best New Product in 2019

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019 / by / in
Domperidone in Treating Patients With Gastrointestinal Disorders
Conditions:   Digestive System Disorder;   Dyspepsia;   Esophagitis;   Gastroesophageal Reflux Disease;   Gastroparesis;   Heartburn;   Nausea and Vomiting
Interventions:   Drug: Domperidone;   Other: Questionnaire Administration
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 7, 2019 / by / in
A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis
Condition:   Gastroparesis
Interventions:   Drug: CIN-102 Dose 1;   Drug: CIN-102 Dose 2;   Drug: CIN-102 Dose 3;   Drug: Placebo
Sponsor:   CinDome Pharma, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 7, 2019 / by / in
Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C
Conditions:   Peritoneal Carcinomatosis;   Colorectal Cancer;   Appendiceal Cancer;   Peritoneal Mesothelioma;   Pseudomyxoma Peritonei;   Gastric Cancer
Interventions:   Procedure: HIPEC;   Drug: Mitomycin C
Sponsor:   Albert Einstein College of Medicine
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 6, 2019 / by / in
Evaluation of the Length of Treatment With PD-1/PD-L1 Inhibitors in Patients With Advanced Solid Tumors
Conditions:   Advanced Solid Tumors;   NSCLC;   Bladder Cancer;   HNSCC;   Renal Cancer;   Melanoma;   Anal Cancer;   Colorectal Cancer;   Cholangiocarcinoma;   Gastric Cancer;   Hepatocellular Carcinoma
Interventions:   Drug: Continue PD-1/PD-L1 Inhibitors treatment;   Other: Discontinue PD-1/PD-L1-1 inhibitor
Sponsor:   Antoinette J Wozniak
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 5, 2019 / by / in
A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer
Conditions:   Carcinoma, Squamous Cell of Head and Neck;   Carcinoma, Non-Small-Cell Lung;   Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma;   Non-small Cell Lung Cancer;   Human Papilloma Virus
Interventions:   Biological: ilixadencel;   Drug: Pembrolizumab
Sponsors:   Immunicum AB;   PPD
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 30, 2019 / by / in
Cancer Experience Registry: An Online Initiative to Understand the Experiences of Those Impacted by a Cancer Diagnosis
Condition:   Cancers
Intervention:  
Sponsor:   Cancer Support Community, Research and Training Institute, Philadelphia
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 28, 2019 / by / in
A Study to Assess the Antitumor Activity, Safety, Pharmacokinetics and Biomarkers of Zolbetuximab (IMAB362) in Participants With Claudin (CLDN) 18.2 Positive, Metastatic or Advanced Unresectable Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Conditions:   Pharmacokinetics of Zolbetuximab;   Gastric Cancer;   Gastro-esophageal Junction (GEJ) Cancer;   Pharmacokinetics of Oxaliplatin;   Pharmacokinetics of Fluorouracil Bolus (5-FU)
Interventions:   Drug: zolbetuximab;   Drug: oxaliplatin;   Drug: leucovorin;   Drug: fluorouracil
Sponsor:   Astellas Pharma Global Development, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 28, 2019 / by / in
Comparison Between Gastric Band, Laparoscopic Sleeve Gastrectomy, Gastric Bypass Surgeries
Condition:   Obese Adolescents
Intervention:  
Sponsor:   Yale University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 27, 2019 / by / in
Study of ImmunoPet Imaging of PD-L1 in Tumors Using 89Zr-DFO-REGN3504 in Patients With Advanced Thoracic Malignancies or Hepatocellular Carcinoma
Conditions:   Advanced Thoracic Malignancies;   Hepatocellular Carcinoma;   Gastroesophageal Junction Adenocarcinoma;   Gastric Cancer
Intervention:   Drug: 89Zr˗DFO˗REGN3504
Sponsor:   Regeneron Pharmaceuticals
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 26, 2019 / by / in
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
Conditions:   Melanoma;   Breast Cancer;   Merkel Cell Carcinoma;   Squamous Cell Cancer;   Non Small Cell Lung Cancer;   Cervical Cancer;   Urothelial Carcinoma;   Ovarian Cancer;   Hepatocellular Carcinoma;   Small-cell Lung Cancer;   Microsatellite Instability High;   Gastric Cancer;   Esophageal Cancer
Interventions:   Device: Echopulse;   Drug: Imiquimod;   Drug: Standard of Care PD-1 Therapy
Sponsors:   Craig L Slingluff, Jr;   Theraclion
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 26, 2019 / by / in